| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS30079080 | HIV | ENSG00000169836.5 | protein_coding | TACR3 | No | No | 6870 | P29371 |
| TVIS30060720 | HIV | ENSG00000169836.5 | protein_coding | TACR3 | No | No | 6870 | P29371 |
| TVIS20033534 | HPV | ENSG00000169836.5 | protein_coding | TACR3 | No | No | 6870 | P29371 |
| TVIS20058844 | HPV | ENSG00000169836.5 | protein_coding | TACR3 | No | No | 6870 | P29371 |
| TVIS20057902 | HPV | ENSG00000169836.5 | protein_coding | TACR3 | No | No | 6870 | P29371 |
| TVIS44008558 | HTLV-1 | ENSG00000169836.5 | protein_coding | TACR3 | No | No | 6870 | P29371 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | TACR3 |
|---|---|
| DrugBank ID | DB04872 |
| Drug Name | Osanetant |
| Target ID | BE0002371 |
| UniProt ID | P29371 |
| Regulation Type | |
| PubMed IDs | 17172464 |
| Citations | Tian G, Wilkins D, Scott CW: Neurokinin-3 receptor-specific antagonists talnetant and osanetant show distinct mode of action in cellular Ca2+ mobilization but display similar binding kinetics and identical mechanism of binding in ligand cross-competition. Mol Pharmacol. 2007 Mar;71(3):902-11. Epub 2006 Dec 15. |
| Groups | Investigational |
| Direct Classification | 1-benzoylpiperidines |
| SMILES | CN(C(C)=O)C1(CCN(CCC[C@@]2(CCCN(C2)C(=O)C2=CC=CC=C2)C2=CC(Cl)=C(Cl)C=C2)CC1)C1=CC=CC=C1 |
| Pathways | |
| PharmGKB | |
| ChEMBL | CHEMBL346178 |
